Pyruvate improves cerebral metabolism during hemorrhagic shock

P D Mongan1, J Capacchione, J L Fontana

  • 1Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA. pmongan@usuhs.mil

Summary

Pyruvate (PYR) administration during hemorrhagic shock improved brain function and survival in swine. PYR stabilized cellular energy and reduced harmful metabolic byproducts, demonstrating its therapeutic potential for critical care.